Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Samia Joseph Khoury, M.D.


The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R13NS080494 (KHOURY, SAMIA J.) Sep 1, 2012 - Aug 31, 2013
    11th International Congress of Neuroimmunology
    Role: Principal Investigator
  2. R56AI093838 (KHOURY, SAMIA J.) Aug 15, 2012 - Jul 31, 2014
    Neural Stem Cells and Regulatory T Cells
    Role: Principal Investigator
  3. R01AI067472 (KHOURY, SAMIA J.) Apr 1, 2008 - Sep 30, 2013
    Role: Principal Investigator
  4. R01AI071448 (KHOURY, SAMIA J.) Apr 1, 2007 - Mar 31, 2011
    Impact of IFN-gamma on Neural Stem Cell Repair Potential in EAE
    Role: Principal Investigator
  5. R56AI058680 (KHOURY, SAMIA J.) Dec 1, 2003 - May 31, 2011
    Role and mechanism of negative costimulatory pathways in EAE
    Role: Principal Investigator

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Zhu C, Zhou Z, Roos I, Merlo D, Kalincik T, Ozakbas S, Skibina O, Kuhle J, Hodgkinson S, Boz C, Alroughani R, Lechner-Scott J, Barnett M, Izquierdo G, Prat A, Horakova D, Kubala Havrdova E, Macdonell R, Patti F, Khoury SJ, Slee M, Karabudak R, Onofrj M, Van Pesch V, Prevost J, Monif M, Jokubaitis V, van der Walt A, Butzkueven H. Comparing switch to ocrelizumab, cladribine or natalizumab after fingolimod treatment cessation in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2022 Dec; 93(12):1330-1337. PMID: 36261289.
    Citations:    Fields:    Translation:Humans
  2. El Ayoubi NK, Sabbagh HM, Bou Rjeily N, Hannoun S, Khoury SJ. Rate of Retinal Layer Thinning as a Biomarker for Conversion to Progressive Disease in Multiple Sclerosis. Neurol Neuroimmunol Neuroinflamm. 2022 11; 9(6). PMID: 36229190; PMCID: PMC9562042.
    Citations:    Fields:    Translation:Humans
  3. Sharmin S, Malpas CB, Roos I, Diouf I, Alroughani R, Ozakbas S, Izquierdo G, Eichau S, Horakova D, Havrdova EK, Patti F, Terzi M, Boz C, Yamout B, Khoury SJ, Onofrj M, Lugaresi A, Altintas A, Prat A, Girard M, Duquette P, Sá MJ, La Spitaleri D, Sidhom Y, Gouider R, Mrabet S, Soysal A, Turkoglu R, Amato MP, Fragoso YD, Kalincik T. Early predictors of disability in paediatric multiple sclerosis: evidence from a multi-national registry. J Neurol Neurosurg Psychiatry. 2022 Sep 30. PMID: 36180218.
    Citations:    Fields:    
  4. Signori A, Lorscheider J, Vukusic S, Trojano M, Iaffaldano P, Hillert J, Hyde R, Pellegrini F, Magyari M, Koch-Henriksen N, Sørensen PS, Spelman T, van der Walt A, Horakova D, Havrdova E, Girard M, Eichau S, Grand'Maison F, Gerlach O, Terzi M, Ozakbas S, Skibina O, Van Pesch V, Sa MJ, Prevost J, Alroughani R, McCombe PA, Gouider R, Mrabet S, Castillo-Trivino T, Zhu C, de Gans K, Sánchez-Menoyo JL, Yamout B, Khoury S, Sormani MP, Kalincik T, Butzkueven H. Heterogeneity on long-term disability trajectories in patients with secondary progressive MS: a latent class analysis from Big MS Data network. J Neurol Neurosurg Psychiatry. 2022 Sep 28. PMID: 36171104.
    Citations:    Fields:    
  5. Ayoubi NKE, Moussa H, Younes A, Haddad R, Khoury SJ. Use of retinal optical coherence tomography to differentiate suspected neuromyelitis optica spectrum disorder from multiple sclerosis: A cross-sectional study. Mult Scler Relat Disord. 2022 Sep 07; 68:104160. PMID: 36113276.
    Citations:    Fields:    
  6. Roos I, Malpas C, Leray E, Casey R, Horakova D, Havrdova EK, Debouverie M, Patti F, De Seze J, Izquierdo G, Eichau S, Edan G, Prat A, Girard M, Ozakbas S, Grammond P, Zephir H, Ciron J, Maillart E, Moreau T, Amato MP, Labauge P, Alroughani R, Buzzard K, Skibina O, Terzi M, Laplaud DA, Berger E, Grand'Maison F, Lebrun-Frenay C, Cartechini E, Boz C, Lechner-Scott J, Clavelou P, Stankoff B, Prevost J, Kappos L, Pelletier J, Shaygannejad V, Yamout BI, Khoury SJ, Gerlach O, Spitaleri DLA, Van Pesch V, Gout O, Turkoglu R, Heinzlef O, Thouvenot E, McCombe PA, Soysal A, Bourre B, Slee M, Castillo-Trivino T, Bakchine S, Ampapa R, Butler EG, Wahab A, Macdonell RA, Aguera-Morales E, Cabre P, Ben NH, Van der Walt A, Laureys G, Van Hijfte L, Ramo-Tello CM, Maubeuge N, Hodgkinson S, Sánchez-Menoyo JL, Barnett MH, Labeyrie C, Vucic S, Sidhom Y, Gouider R, Csepany T, Sotoca J, de Gans K, Al-Asmi A, Fragoso YD, Vukusic S, Butzkueven H, Kalincik T. Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis. Neurology. 2022 Oct 25; 99(17):e1926-e1944. PMID: 35977837; PMCID: PMC9620810.
    Citations:    Fields:    Translation:Humans
  7. Hitti E, Hadid D, Khoury SJ, Tamim H, Makki M, Karam CM. Domestic tethers: Gender differences in career paths and domestic responsibilities of top-research medical school graduates. PLoS One. 2022; 17(4):e0267288. PMID: 35442989; PMCID: PMC9020711.
    Citations:    Fields:    Translation:Humans
  8. Kaplan TB, Gopal A, Block VJ, Suskind AM, Zhao C, Polgar-Turcsanyi M, Saraceno TJ, Gomez R, Santaniello A, Consortium S, Ayoubi NE, Cree BAC, Hauser SL, Weiner H, Chitnis T, Khoury S, Bove R. Challenges to Longitudinal Characterization of Lower Urinary Tract Dysfunction in Multiple Sclerosis. Mult Scler Relat Disord. 2022 Jun; 62:103793. PMID: 35461057.
    Citations:    Fields:    Translation:Humans
  9. Dahham J, Rizk R, Hiligsmann M, Daccache C, Khoury SJ, Darwish H, Evers S, Kremer I. The Economic and societal burden of multiple sclerosis on lebanese society: a cost-of-illness and quality of life study protocol. Expert Rev Pharmacoecon Outcomes Res. 2022 Jul; 22(5):869-876. PMID: 34826264.
    Citations:    Fields:    Translation:Humans
  10. Chaaban L, Safwan N, Moussa H, El-Sammak S, Khoury SJ, Hannoun S. Central vein sign: A putative diagnostic marker for multiple sclerosis. Acta Neurol Scand. 2022 Mar; 145(3):279-287. PMID: 34796472.
    Citations:    Fields:    Translation:Humans
  11. Saba ES, Karout M, Nasrallah L, Kobeissy F, Darwish H, Khoury SJ. Long-term cognitive deficits after traumatic brain injury associated with microglia activation. Clin Immunol. 2021 09; 230:108815. PMID: 34339843.
    Citations: 1     Fields:    Translation:AnimalsCells
  12. El Ayoubi NK, Bou Reslan SW, Baalbaki MM, Darwish H, Khoury SJ. Effect of fingolimod vs interferon treatment on OCT measurements and cognitive function in RRMS. Mult Scler Relat Disord. 2021 Aug; 53:103041. PMID: 34051694.
    Citations: 1     Fields:    Translation:Humans
  13. Mrad MF, Saba ES, Nakib L, Khoury SJ. Exosomes From Subjects With Multiple Sclerosis Express EBV-Derived Proteins and Activate Monocyte-Derived Macrophages. Neurol Neuroimmunol Neuroinflamm. 2021 07; 8(4). PMID: 34006621; PMCID: PMC8130999.
    Citations: 3     Fields:    Translation:HumansCells
  14. Darwish H, Zeinoun P, Farran N, Ghusn H, Yamout B, Khoury SJ. The Brief International Cognitive Assessment in Multiple Sclerosis (BICAMS): Validation in Arabic and Lebanese Normative Values. J Int Neuropsychol Soc. 2022 01; 28(1):94-103. PMID: 33563350.
    Citations:    Fields:    Translation:Humans
  15. Jaafar N, Khoueiry M, Khoury SJ, Makki A. Rare Case of Spinal Neurosarcoidosis with Concomitant Epidural Lipomatosis. Case Rep Neurol Med. 2021; 2021:5952724. PMID: 33604089; PMCID: PMC7869444.
    Citations: 1     
  16. Khoury SJ. Progressive Multiple Sclerosis. Ann Neurol. 2020 09; 88(3):436-437. PMID: 32628321.
    Citations:    Fields:    Translation:Humans
  17. Zeinoun P, Farran N, Khoury SJ, Darwish H. Development, psychometric properties, and pilot norms of the first Arabic indigenous memory test: The Verbal Memory Arabic Test (VMAT). J Clin Exp Neuropsychol. 2020 07; 42(5):505-515. PMID: 32567997.
    Citations:    Fields:    Translation:Humans
  18. Amor S, Baker D, Khoury SJ, Schmierer K, Giovanonni G. SARS-CoV-2 and Multiple Sclerosis: Not All Immune Depleting DMTs are Equal or Bad. Ann Neurol. 2020 06; 87(6):794-797. PMID: 32383812.
    Citations: 22     Fields:    Translation:HumansCellsPHPublic Health
  19. Darwish H, Farran N, Hannoun S, Tadros N, Yamout B, El Ayoubi NK, Khoury SJ. Serum vitamin D level is associated with speed of processing in multiple sclerosis patients. J Steroid Biochem Mol Biol. 2020 06; 200:105628. PMID: 32061642.
    Citations: 1     Fields:    Translation:Humans
  20. Khoury SJ, Tintore M. Multiple sclerosis in the Middle East and North Africa region. Mult Scler J Exp Transl Clin. 2020 Jan-Mar; 6(1):2055217319895540. PMID: 35145729; PMCID: PMC8822444.
  21. Mayssam EN, Eid C, Khoury SJ, Hannoun S. "No evidence of disease activity": Is it an aspirational therapeutic goal in multiple sclerosis? Mult Scler Relat Disord. 2020 May; 40:101935. PMID: 31951861.
    Citations: 4     Fields:    Translation:Humans
  22. Tamim H, Zeineldine S, Tabbara F, Khoury S, Akiki Z, Khansa S, Taher A. Structure and evaluation of a residency research program in a university hospital. BMC Med Educ. 2019 Nov 06; 19(1):406. PMID: 31694614; PMCID: PMC6836359.
    Citations: 1     Fields:    Translation:Humans
  23. Yamout B, Sahraian M, Bohlega S, Al-Jumah M, Goueider R, Dahdaleh M, Inshasi J, Hashem S, Alsharoqi I, Khoury S, Alkhawajah M, Koussa S, Al Khaburi J, Almahdawi A, Alsaadi T, Slassi E, Daodi S, Zakaria M, Alroughani R. Consensus recommendations for the diagnosis and treatment of multiple sclerosis: 2019 revisions to the MENACTRIMS guidelines. Mult Scler Relat Disord. 2020 Jan; 37:101459. PMID: 31670208.
    Citations: 15     Fields:    Translation:Humans
  24. Maalouf FT, Alamiri B, Atweh S, Becker AE, Cheour M, Darwish H, Ghandour LA, Ghuloum S, Hamze M, Karam E, Khoury B, Khoury SJ, Mokdad A, Meho LI, Okasha T, Reed GM, Sbaity E, Zeinoun P, Akl EA. Mental health research in the Arab region: challenges and call for action. Lancet Psychiatry. 2019 11; 6(11):961-966. PMID: 31327707.
    Citations: 15     Fields:    Translation:Humans
  25. Alroughani R, Akhtar S, Zeineddine M, El Kouzi Y, El Ayoubi NK, Ahmed SF, Behbehani R, Khoury SJ, Al-Hashel JY, Yamout BI. Risk of relapses during pregnancy among multiple sclerosis patients. Mult Scler Relat Disord. 2019 Sep; 34:9-13. PMID: 31202959.
    Citations: 7     Fields:    Translation:Humans
  26. Chehabeddine L, Al Saleh T, Baalbaki M, Saleh E, Khoury SJ, Hannoun S. Cumulative administrations of gadolinium-based contrast agents: risks of accumulation and toxicity of linear vs macrocyclic agents. Crit Rev Toxicol. 2019 03; 49(3):262-279. PMID: 30942117.
    Citations: 8     Fields:    Translation:HumansPHPublic Health
  27. Glatigny S, Höllbacher B, Motley SJ, Tan C, Hundhausen C, Buckner JH, Smilek D, Khoury SJ, Ding L, Qin T, Pardo J, Nepom GT, Turka LA, Harris KM, Campbell DJ, Bettelli E. Abatacept Targets T Follicular Helper and Regulatory T Cells, Disrupting Molecular Pathways That Regulate Their Proliferation and Maintenance. J Immunol. 2019 03 01; 202(5):1373-1382. PMID: 30683697; PMCID: PMC6481683.
    Citations: 17     Fields:    Translation:HumansCellsCTClinical Trials
  28. Starossom SC, Campo Garcia J, Woelfle T, Romero-Suarez S, Olah M, Watanabe F, Cao L, Yeste A, Tukker JJ, Quintana FJ, Imitola J, Witzel F, Schmitz D, Morkel M, Paul F, Infante-Duarte C, Khoury SJ. Chi3l3 induces oligodendrogenesis in an experimental model of autoimmune neuroinflammation. Nat Commun. 2019 01 15; 10(1):217. PMID: 30644388; PMCID: PMC6333780.
    Citations: 21     Fields:    Translation:HumansAnimalsCells
  29. Kivisäkk P, Khoury SJ. Co-signaling Molecules in Neurological Diseases. Adv Exp Med Biol. 2019; 1189:233-265. PMID: 31758537.
    Citations:    Fields:    Translation:AnimalsCells
  30. Hannoun S, Issa R, El Ayoubi NK, Haddad R, Baalbaki M, Yamout BI, Khoury SJ, Hourani R. Gadoterate Meglumine Administration in Multiple Sclerosis has no Effect on the Dentate Nucleus and the Globus Pallidus Signal Intensities. Acad Radiol. 2019 10; 26(10):e284-e291. PMID: 30527456.
    Citations: 1     Fields:    Translation:Humans
  31. Yamout BI, El-Ayoubi NK, Nicolas J, El Kouzi Y, Khoury SJ, Zeineddine MM. Safety and Efficacy of Rituximab in Multiple Sclerosis: A Retrospective Observational Study. J Immunol Res. 2018; 2018:9084759. PMID: 30539030; PMCID: PMC6260423.
    Citations: 13     Fields:    Translation:Humans
  32. Said M, El Ayoubi NK, Hannoun S, Haddad R, Saba L, Jalkh Y, Yamout BI, Khoury SJ. The Bayesian risk estimate at onset (BREMSO) correlates with cognitive and physical disability in patients with early multiple sclerosis. Mult Scler Relat Disord. 2018 Nov; 26:96-102. PMID: 30243236.
    Citations: 1     Fields:    Translation:Humans
  33. Hannoun S, Baalbaki M, Haddad R, Saaybi S, El Ayoubi NK, Yamout BI, Khoury SJ, Hourani R. Gadolinium effect on thalamus and whole brain tissue segmentation. Neuroradiology. 2018 Nov; 60(11):1167-1173. PMID: 30128599.
    Citations: 2     Fields:    Translation:Humans
  34. Regev K, Healy BC, Paul A, Diaz-Cruz C, Mazzola MA, Raheja R, Glanz BI, Kivisäkk P, Chitnis T, Jagodic M, Piehl F, Olsson T, Khademi M, Hauser S, Oksenberg J, Khoury SJ, Weiner HL, Gandhi R. Identification of MS-specific serum miRNAs in an international multicenter study. Neurol Neuroimmunol Neuroinflamm. 2018 Sep; 5(5):e491. PMID: 30175165; PMCID: PMC6117192.
    Citations: 22     Fields:    
  35. Yamout BI, Sahraian MA, Ayoubi NE, Tamim H, Nicolas J, Khoury SJ, Zeineddine MM. Efficacy and safety of natalizumab extended interval dosing. Mult Scler Relat Disord. 2018 Aug; 24:113-116. PMID: 29982107.
    Citations: 15     Fields:    Translation:Humans
  36. Longbrake EE, Kantor D, Pawate S, Bradshaw MJ, von Geldern G, Chahin S, Cross AH, Parks BJ, Rice M, Khoury SJ, Yamout B, Zeineddine M, Russell-Giller S, Caminero-Rodriguez A, Edwards K, Lathi E, VanderKodde D, Meador W, Berkovich R, Ge L, Bacon TE, Kister I. Effectiveness of alternative dose fingolimod for multiple sclerosis. Neurol Clin Pract. 2018 Apr; 8(2):102-107. PMID: 29708225; PMCID: PMC5914753.
    Citations: 4     
  37. Buttrick TS, Wang W, Yung C, Trieu KG, Patel K, Khoury SJ, Ai X, Elyaman W. Foxo1 Promotes Th9 Cell Differentiation and Airway Allergy. Sci Rep. 2018 01 16; 8(1):818. PMID: 29339772.
    Citations: 12     Fields:    Translation:AnimalsCells
  38. Yamout BI, Khoury SJ, Ayyoubi N, Doumiati H, Fakhreddine M, Ahmed SF, Tamim H, Al-Hashel JY, Behbehani R, Alroughani R. Alternative diagnoses in patients referred to specialized centers for suspected MS. Mult Scler Relat Disord. 2017 Nov; 18:85-89. PMID: 29141828.
    Citations: 7     Fields:    Translation:Humans
  39. Buttrick T, Khoury SJ, Elyaman W. Opposite functions of STAT3 and Smad3 in regulating Tiam1 expression in Th17 cells. Small GTPases. 2020 01; 11(1):62-68. PMID: 28609201.
    Citations: 1     Fields:    Translation:AnimalsCells
  40. Bove R, Chitnis T, Cree BA, Tintoré M, Naegelin Y, Uitdehaag BM, Kappos L, Khoury SJ, Montalban X, Hauser SL, Weiner HL. SUMMIT (Serially Unified Multicenter Multiple Sclerosis Investigation): creating a repository of deeply phenotyped contemporary multiple sclerosis cohorts. Mult Scler. 2018 10; 24(11):1485-1498. PMID: 28847219; PMCID: PMC5821573.
    Citations: 12     Fields:    Translation:Humans
  41. Yamout BI, Said M, Hannoun S, Zeineddine M, Massouh J, Khoury SJ. Rebound syndrome after teriflunomide cessation in a patient with multiple sclerosis. J Neurol Sci. 2017 Sep 15; 380:79-81. PMID: 28870594.
    Citations:    Fields:    Translation:Humans
  42. Mrad MF, El Ayoubi NK, Esmerian MO, Kazan JM, Khoury SJ. Effect of vitamin D replacement on immunological biomarkers in patients with multiple sclerosis. Clin Immunol. 2017 08; 181:9-15. PMID: 28536054.
    Citations: 3     Fields:    Translation:HumansCells
  43. Darwish H, Haddad R, Osman S, Ghassan S, Yamout B, Tamim H, Khoury S. Effect of Vitamin D Replacement on Cognition in Multiple Sclerosis Patients. Sci Rep. 2017 04 04; 7:45926. PMID: 28374837.
    Citations: 13     Fields:    Translation:HumansCTClinical Trials
  44. El Ayoubi NK, Khoury SJ. Blood Biomarkers as Outcome Measures in Inflammatory Neurologic Diseases. Neurotherapeutics. 2017 01; 14(1):135-147. PMID: 27757816.
    Citations: 4     Fields:    Translation:Humans
  45. Azcutia V, Bassil R, Herter JM, Engelbertsen D, Newton G, Autio A, Mayadas T, Lichtman AH, Khoury SJ, Parkos CA, Elyaman W, Luscinskas FW. Defects in CD4+ T cell LFA-1 integrin-dependent adhesion and proliferation protect Cd47-/- mice from EAE. J Leukoc Biol. 2017 02; 101(2):493-505. PMID: 27965383; PMCID: PMC6608006.
    Citations: 6     Fields:    Translation:HumansAnimalsCellsPHPublic Health
  46. Elyaman W, Khoury SJ. Th9 cells in the pathogenesis of EAE and multiple sclerosis. Semin Immunopathol. 2017 01; 39(1):79-87. PMID: 27844107.
    Citations: 23     Fields:    Translation:HumansAnimalsCells
  47. Khoury S, Graczyk T, Burnham G, Jurdi M, Goldman L. Drinking water system treatment and contamination in Shatila Refugee Camp in Beirut, Lebanon. East Mediterr Health J. 2016 Nov 02; 22(8):568-578. PMID: 27834438.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  48. Kurdi AT, Bassil R, Olah M, Wu C, Xiao S, Taga M, Frangieh M, Buttrick T, Orent W, Bradshaw EM, Khoury SJ, Elyaman W. Tiam1/Rac1 complex controls Il17a transcription and autoimmunity. Nat Commun. 2016 10 11; 7:13048. PMID: 27725632.
    Citations: 17     Fields:    Translation:HumansAnimalsCells
  49. El Ayoubi NK, Ghassan S, Said M, Allam J, Darwish H, Khoury SJ. Retinal measures correlate with cognitive and physical disability in early multiple sclerosis. J Neurol. 2016 Nov; 263(11):2287-2295. PMID: 27544501.
    Citations: 11     Fields:    Translation:Humans
  50. Khoury SJ, Rochon J, Ding L, Byron M, Ryker K, Tosta P, Gao W, Freedman MS, Arnold DL, Sayre PH, Smilek DE. ACCLAIM: A randomized trial of abatacept (CTLA4-Ig) for relapsing-remitting multiple sclerosis. Mult Scler. 2017 Apr; 23(5):686-695. PMID: 27481207; PMCID: PMC5288398.
    Citations: 17     Fields:    Translation:Humans
  51. Bou Fakhredin R, Saade C, Kerek R, El-Jamal L, Khoury SJ, El-Merhi F. Imaging in multiple sclerosis: A new spin on lesions. J Med Imaging Radiat Oncol. 2016 Oct; 60(5):577-586. PMID: 27464473.
    Citations: 2     Fields:    Translation:Humans
  52. Yamout BI, Abou Zeid N, Taha AJ, Zeineddine MM, Khoury SJ. Three cases of herpes zoster radiculitis in MS patients treated with natalizumab. Mult Scler Relat Disord. 2016 Sep; 9:122-4. PMID: 27645358.
    Citations:    Fields:    Translation:Humans
  53. Dagher MM, Atieh JA, Soubra MK, Khoury SJ, Tamim H, Kaafarani BR. Medical Research Volunteer Program (MRVP): innovative program promoting undergraduate research in the medical field. BMC Med Educ. 2016 Jun 06; 16:160. PMID: 27267261.
    Citations: 9     Fields:    Translation:Humans
  54. Fawaz L, Mrad MF, Kazan JM, Sayegh S, Akika R, Khoury SJ. Comparative effect of 25(OH)D3 and 1,25(OH)2D3 on Th17 cell differentiation. Clin Immunol. 2016 May; 166-167:59-71. PMID: 27041081.
    Citations: 24     Fields:    Translation:HumansCells
  55. Orent W, Mchenry AR, Rao DA, White C, Klein HU, Bassil R, Srivastava G, Replogle JM, Raj T, Frangieh M, Cimpean M, Cuerdon N, Chibnik L, Khoury SJ, Karlson EW, Brenner MB, De Jager P, Bradshaw EM, Elyaman W. Rheumatoid arthritis-associated RBPJ polymorphism alters memory CD4+ T cells. Hum Mol Genet. 2016 Jan 15; 25(2):404-17. PMID: 26604133; PMCID: PMC4881829.
    Citations: 4     Fields:    Translation:HumansCells
  56. Alroughani R, Akhtar S, Ahmed SF, Khoury SJ, Al-Hashel JY, Sahraian MA, Al Jumah M, Zeineddine M, Farhat S, Doumiati H, Yamout BI. JC virus seroprevalence and seroconversion in multiple sclerosis cohort: A Middle-Eastern study. J Neurol Sci. 2016 Jan 15; 360:61-5. PMID: 26723975.
    Citations: 10     Fields:    Translation:HumansCells
  57. Yamout BI, Zeineddine MM, Tamim H, Khoury SJ. Safety and efficacy of fingolimod in clinical practice: The experience of an academic center in the Middle East. J Neuroimmunol. 2015 Dec 15; 289:93-7. PMID: 26616877.
    Citations: 10     Fields:    Translation:Humans
  58. Darwish H, Zeinoun P, Ghusn H, Khoury B, Tamim H, Khoury SJ. Serum 25-hydroxyvitamin D predicts cognitive performance in adults. Neuropsychiatr Dis Treat. 2015; 11:2217-23. PMID: 26346368; PMCID: PMC4556248.
    Citations: 12     
  59. Merzaban JS, Imitola J, Starossom SC, Zhu B, Wang Y, Lee J, Ali AJ, Olah M, Abuelela AF, Khoury SJ, Sackstein R. Cell surface glycan engineering of neural stem cells augments neurotropism and improves recovery in a murine model of multiple sclerosis. Glycobiology. 2015 Dec; 25(12):1392-409. PMID: 26153105.
    Citations: 21     Fields:    Translation:AnimalsCells
  60. Yamout B, Alroughani R, Al-Jumah M, Goueider R, Dahdaleh M, Inshasi J, Hashem S, Alsharoqi I, Sahraian M, Khoury S, Alkawi Z, Koussa S, Zakaria M, Al Khaburi J, Alsaadi T, Bohlega S. Consensus recommendations for the diagnosis and treatment of multiple sclerosis: the Middle East North Africa Committee for Treatment and Research In Multiple Sclerosis (MENACTRIMS). Curr Med Res Opin. 2015; 31(7):1349-61. PMID: 25946578.
    Citations: 5     Fields:    Translation:Humans
  61. Yamout BI, Zeineddine MM, Sawaya RA, Khoury SJ. Safety and efficacy of reduced fingolimod dosage treatment. J Neuroimmunol. 2015 Aug 15; 285:13-5. PMID: 26198913.
    Citations: 8     Fields:    Translation:HumansCells
  62. Mouhieddine TH, Darwish H, Fawaz L, Yamout B, Tamim H, Khoury SJ. Risk factors for multiple sclerosis and associations with anti-EBV antibody titers. Clin Immunol. 2015 May; 158(1):59-66. PMID: 25805657.
    Citations: 7     Fields:    Translation:HumansCells
  63. Kivisäkk P, Francois K, Mbianda J, Gandhi R, Weiner HL, Khoury SJ. Effect of natalizumab treatment on circulating plasmacytoid dendritic cells: a cross-sectional observational study in patients with multiple sclerosis. PLoS One. 2014; 9(7):e103716. PMID: 25075741.
    Citations: 5     Fields:    Translation:HumansCells
  64. Bassil R, Orent W, Olah M, Kurdi AT, Frangieh M, Buttrick T, Khoury SJ, Elyaman W. BCL6 controls Th9 cell development by repressing Il9 transcription. J Immunol. 2014 Jul 01; 193(1):198-207. PMID: 24879792; PMCID: PMC4130220.
    Citations: 25     Fields:    Translation:AnimalsCells
  65. Messina S, Vargas-Lowy D, Musallam A, Healy BC, Kivisakk P, Gandhi R, Bove R, Gholipour T, Khoury S, Weiner HL, Chitnis T. Increased leptin and A-FABP levels in relapsing and progressive forms of MS. BMC Neurol. 2013 Nov 11; 13:172. PMID: 24215402.
    Citations: 11     Fields:    Translation:Humans
  66. Ottoboni L, Frohlich IY, Lee M, Healy BC, Keenan BT, Xia Z, Chitnis T, Guttmann CR, Khoury SJ, Weiner HL, Hafler DA, De Jager PL. Clinical relevance and functional consequences of the TNFRSF1A multiple sclerosis locus. Neurology. 2013 Nov 26; 81(22):1891-9. PMID: 24174586; PMCID: PMC3843384.
    Citations: 13     Fields:    Translation:HumansAnimalsCells
  67. Yamout B, El-Salem K, Gebeily S, Khoury S, Abu Zeid N, Hamoulila K, Alhalabi MS, Hasan ZN, Al Hamadani H, Hamoodi H, Al Omar A, Dahdaleh M. Multiple sclerosis in the Levant: a regional consensus statement. Int J Neurosci. 2014 May; 124(5):377-82. PMID: 23927564.
    Citations: 1     Fields:    Translation:Humans
  68. Kivisäkk P, Healy BC, Francois K, Gandhi R, Gholipour T, Egorova S, Sevdalinova V, Quintana F, Chitnis T, Weiner HL, Khoury SJ. Evaluation of circulating osteopontin levels in an unselected cohort of patients with multiple sclerosis: relevance for biomarker development. Mult Scler. 2014 Apr; 20(4):438-44. PMID: 24005026.
    Citations: 17     Fields:    Translation:Humans
  69. Zhu B, Buttrick T, Bassil R, Zhu C, Olah M, Wu C, Xiao S, Orent W, Elyaman W, Khoury SJ. IL-4 and retinoic acid synergistically induce regulatory dendritic cells expressing Aldh1a2. J Immunol. 2013 Sep 15; 191(6):3139-51. PMID: 23960232; PMCID: PMC3773474.
    Citations: 24     Fields:    Translation:AnimalsCells
  70. Chitnis T, Khoury SJ. Sex influences in autoimmune disease. Clin Immunol. 2013 Nov; 149(2):169. PMID: 24012474.
    Citations:    Fields:    Translation:Humans
  71. Gandhi R, Healy B, Gholipour T, Egorova S, Musallam A, Hussain MS, Nejad P, Patel B, Hei H, Khoury S, Quintana F, Kivisakk P, Chitnis T, Weiner HL. Circulating microRNAs as biomarkers for disease staging in multiple sclerosis. Ann Neurol. 2013 Jun; 73(6):729-40. PMID: 23494648.
    Citations: 99     Fields:    Translation:Humans
  72. Bove R, Musallam A, Healy BC, Houtchens M, Glanz BI, Khoury S, Guttmann CR, De Jager PL, Chitnis T. No sex-specific difference in disease trajectory in multiple sclerosis patients before and after age 50. BMC Neurol. 2013 Jul 03; 13:73. PMID: 23822612.
    Citations: 11     Fields:    Translation:Humans
  73. Yamout B, Alroughani R, Al-Jumah M, Khoury S, Abouzeid N, Dahdaleh M, Alsharoqi I, Inshasi J, Hashem S, Zakaria M, ElKallab K, Alsaadi T, Tawfeek T, Bohlega S. Consensus guidelines for the diagnosis and treatment of multiple sclerosis. Curr Med Res Opin. 2013 Jun; 29(6):611-21. PMID: 23514115.
    Citations: 4     Fields:    Translation:Humans
  74. Abrams P, Chapple C, Khoury S, Roehrborn C, de la Rosette J. Evaluation and treatment of lower urinary tract symptoms in older men. J Urol. 2013 Jan; 189(1 Suppl):S93-S101. PMID: 23234640.
    Citations: 30     Fields:    Translation:Humans
  75. Vargas-Lowy D, Kivisäkk P, Gandhi R, Raddassi K, Soltany P, Gorman MP, Khoury SJ, Chitnis T. Increased Th17 response to myelin peptides in pediatric MS. Clin Immunol. 2013 Mar; 146(3):176-84. PMID: 23352968.
    Citations: 10     Fields:    Translation:HumansCells
  76. Ottoboni L, Keenan BT, Tamayo P, Kuchroo M, Mesirov JP, Buckle GJ, Khoury SJ, Hafler DA, Weiner HL, De Jager PL. An RNA profile identifies two subsets of multiple sclerosis patients differing in disease activity. Sci Transl Med. 2012 Sep 26; 4(153):153ra131. PMID: 23019656.
    Citations: 28     Fields:    Translation:HumansCells
  77. Cousens LP, Najafian N, Mingozzi F, Elyaman W, Mazer B, Moise L, Messitt TJ, Su Y, Sayegh M, High K, Khoury SJ, Scott DW, De Groot AS. In vitro and in vivo studies of IgG-derived Treg epitopes (Tregitopes): a promising new tool for tolerance induction and treatment of autoimmunity. J Clin Immunol. 2013 Jan; 33 Suppl 1:S43-9. PMID: